| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/08/2008 | US20080108709 fine oil-in-water emulsion comprising quaternary ammonium compounds, providing prolonged-stability, low-viscosity, clear to transparent microemulsion-like concentrates; use in cosmetic, dermatological, pharmaceutical field; wet wipes, sprayable care emulsions; free of polyethylene glycol |
| 05/08/2008 | US20080108708 Method for Producing Albumin Conjugates Containing Gyrase Inhibitors |
| 05/08/2008 | US20080108606 Side effect reduction; antiproliferative agents; schizophrenia |
| 05/08/2008 | US20080108590 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickenier; extended time high blood serum concentration; rapidly absorbed gel |
| 05/08/2008 | US20080108576 Novel cytostatic conjugates with integrin ligands |
| 05/08/2008 | US20080108575 Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 05/08/2008 | US20080108570 Treating a skin wrinkle; reduced toxicity and/or a reduced immunogenicity, storage stability; e.g. hydroxyalkyl starch; genetic engineered albumin |
| 05/08/2008 | US20080108545 Peptide nucleic acid linked via a disulfide bond to a triphenylphosphonium group; deliver PNA oligomers across the plasma membrane into cells; HIV infection, hepatitis C infection; melanoma, pancreatic adnocarcinoma, actue myeloid leukemia, myeloma, small cell lung cancer, prostate cancer |
| 05/08/2008 | US20080108544 2-naphthalenealkanol, 1,2,3,4,5,6,7,8-octahydro-alpha,2,3,8,8-pentamethyl- or esters thereof; woody, sweet, buttery, fatty, ambery, musky, patchouli, grisalva, ionone fragrance notes; colognes, cosmetics, personal care products, cleaning products, air fresheners, detergents, fabric care products |
| 05/08/2008 | US20080108139 Composition of matter comprising primary nucleic acid component |
| 05/08/2008 | US20080108135 Using immunoglobulin fusion to deliver effector cells; tissue targeted therapy; antitumor agents |
| 05/08/2008 | US20080107777 Process for production of compounds, which are starch containing particles coated, embedded or encapsulated by at least one biopolymers |
| 05/08/2008 | US20080107776 Non-caloric, low-caloric natural and/or synthetic; provide a more sugar-like temporal profile, including sweetness onset and sweetness linger, and/or a more sugar-like flavor profile; isoflavones, stilbenes, lignans, resorcyclic acid lactones; genistein, daidzein, glycitein, biochanin A, formononetin |
| 05/08/2008 | US20080107749 Polymeric nanoparticles with hydrophobic core and hydrophilic shell N-isopropyl acrylamide; oral or parenteral; water-soluble vinylpyrolidone, vinyl acetate; or water insoluble methyl methacrylate, styrene, acrylic acid; chemotherapeutics, contrasting agents, antibodies, radionucleides, ligands, medicine |
| 05/08/2008 | US20080107745 Controlled release sterile injectable aripiprazole formulation and method |
| 05/08/2008 | US20080107741 Angiogenesis inhibitor particles having a particle size of less than 2000 nm; and associated with the surface thereof at least one surface stabilizer |
| 05/08/2008 | US20080107731 Dipeptidyl peptidase IV inhibitor; diluents of cellulose powder, dibasic calciumphosphate anhydrous, erythritol; binder of copovidone, hydroxypropyl methylcellulose; disintegrant corn starch; lubricant of talc, polyethyleneglycol, calcium behenate, calcium stearate; glidant is colloidal silicon dioxide |
| 05/08/2008 | US20080107730 Sustained release pharmaceutical preparations and methods for producing the same |
| 05/08/2008 | US20080107729 Orally disintegrating compositions |
| 05/08/2008 | US20080107726 Compositions comprising beta-adrenergic receptor antagonists and diuretics |
| 05/08/2008 | US20080107724 Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules |
| 05/08/2008 | US20080107720 Topical delivery of codrugs |
| 05/08/2008 | US20080107715 Food product; carbohydrate, fat, protein, vitamins, minerals and electrolytes; post-obesity-surgery patient; modulating appetite, hyperlipidemia, hypertension, diabetes, sleep apnea, degenerative joint disease, or depression |
| 05/08/2008 | US20080107709 Radio-opaque polymeric biomaterials |
| 05/08/2008 | US20080107704 Block Biodegradable Copolymers for Medical Devices |
| 05/08/2008 | US20080107697 Such as erythritol, xylitol, sorbitol and glucose; wear resistant makeup |
| 05/08/2008 | US20080107694 Glycolic acid-lactic acid copolymer; biocompatible; biodegradable; RNA interference; inhibitors of vascular endothelial growth factor (VEGF); ocular disorders |
| 05/08/2008 | US20080107660 Binding Agents |
| 05/08/2008 | US20080107631 Liquid mixture comprising cryoprotectants and lyoprotectants for use in long term storage of viral particles |
| 05/08/2008 | US20080107617 Surfactant-containing cosmetic, dermatological and pharmaceutical agents |
| 05/08/2008 | US20080105546 Electrohydrodynamic method for processing liquids using electric fields without denaturing biological material or sensitive molecules, and thus benefits from producing comminutes with controlled diameter and charge |
| 05/08/2008 | CA2668045A1 Peptide chimeric molecules having antiviral properties against viruses of the flaviviridae family |
| 05/08/2008 | CA2668020A1 Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infection |
| 05/08/2008 | CA2668017A1 Improved conjugates |
| 05/08/2008 | CA2667970A1 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii) |
| 05/08/2008 | CA2667864A1 Formulations of phospholipase enzyme inhibitors |
| 05/08/2008 | CA2667664A1 Use of a fusion protein targeting the ed-b fibronectin domain for treatment of atherosclerosis |
| 05/08/2008 | CA2666534A1 W/o/w emulsion composition |
| 05/08/2008 | CA2664304A1 Use of pegylated il-10 to treat cancer |
| 05/08/2008 | CA2656112A1 Bioresponsive polymers |
| 05/08/2008 | CA2634783A1 Anti-hyperproliferative therapies targeting hdgf |
| 05/07/2008 | EP1918380A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918304A1 Monoclonal antibodies against the human anti-müllerian hormone type II receptor (AMHR-II) |
| 05/07/2008 | EP1917980A1 Use of a fusion protein between a cytokine and an antibody targeting the ED-B fibronectin domain for the treatment of atherosclerosis |
| 05/07/2008 | EP1917976A1 Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration |
| 05/07/2008 | EP1917971A1 Substained release formulations comprising very low molecular weight polymers |
| 05/07/2008 | EP1917964A1 Percutaneously absorbable ophthalmic preparation |
| 05/07/2008 | EP1917962A1 Pharmaceutical composition for modified release insulin sensitiser |
| 05/07/2008 | EP1917961A1 Capsinoid containing composition |
| 05/07/2008 | EP1917958A2 Improved HIV protease inhibitors pharmaceutical formulations |
| 05/07/2008 | EP1917072A2 Vitamin formulation |
| 05/07/2008 | EP1917037A2 Peg-ifn alpha and ribavirin for hbv treatment |
| 05/07/2008 | EP1917036A2 Intermolecular association complex of a carrier and of an active principle |
| 05/07/2008 | EP1917035A2 Peroxide removal from drug delivery vehicle |
| 05/07/2008 | EP1917004A2 Method for encapsulating therapeutic substances in cells |
| 05/07/2008 | EP1917003A1 Seamless coated spherical filled capsules |
| 05/07/2008 | EP1916997A2 Stable aqueous protein or antibody pharmaceutical formulations and their preparation |
| 05/07/2008 | EP1916996A2 Production of an oxaliplatin mixture and a container and a container set for said mixture |
| 05/07/2008 | EP1916995A1 Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
| 05/07/2008 | EP1603596B1 Liquid formulations of tumor necrosis factor-binding protein tbp-1 |
| 05/07/2008 | EP1551899B1 Biodegradable phase separated segmented multi block co-polymers |
| 05/07/2008 | EP1467757B1 Use of antibodies against the muc18 antigen |
| 05/07/2008 | EP1360208B1 Method for the production of cytotoxic anti-cancer antibodies |
| 05/07/2008 | CN101175855A Anti-MUC1 a/ss antibodies |
| 05/07/2008 | CN101175512A Medical composition for promotion of skin regeneration |
| 05/07/2008 | CN101175498A Intravenous formulations of pyridoxal 5'-phosphate and method of preparation |
| 05/07/2008 | CN101175497A Pharmaceutical composition comprising an oleaginous ointment and vitamin d or the derivatives thereof in solubilised form |
| 05/07/2008 | CN101175496A Prostaglandin F2a derivative inclusion product |
| 05/07/2008 | CN101175490A Agent for improving circulatory disorder |
| 05/07/2008 | CN101175486A Nanoparticles of chitosan and polyethyleneglycol as a system for the administration of biologically-active molecules |
| 05/07/2008 | CN101175478A Non-protein stabilized clostridial toxin pharmaceutical compositions |
| 05/07/2008 | CN101173295A Compositions and methods for identifying antigens which elicit an immune response |
| 05/07/2008 | CN101172161A Water-soluble polymers decorated G-CSF conjugates |
| 05/07/2008 | CN101172160A Interferon gamma conjugates |
| 05/07/2008 | CN101172159A Acidic biological adhesion heat-variable gelling agent, its preparing method and uses |
| 05/07/2008 | CN101172132A Self-emulsifying preparations for treating gastropathy and preparation method thereof |
| 05/07/2008 | CN101172104A Processes of making and using pharmaceutical formulations of antineoplastic agents |
| 05/07/2008 | CN101172102A Water-solubility cozymase Q* supermolecule composition and method for preparing the same |
| 05/07/2008 | CN101172101A Glipizide controlled release tablets and preparation method thereof |
| 05/07/2008 | CN101172100A Stable isotonic lyophilized protein formulation |
| 05/07/2008 | CN101172099A Stable isotonic lyophilized protein formulation |
| 05/07/2008 | CN101172098A Safe and environment-protecting solid inhalator propellant |
| 05/07/2008 | CN101172096A Target controlling and releasing system for magnetic microsphere carrier in bipolar precipitous magnetic field impulse hunting magnetic field |
| 05/07/2008 | CN101171927A Choline-silicic acid complex with osmolytes and divalent trace elements |
| 05/07/2008 | CN100386427C Bifidobacterium and products containing the same |
| 05/07/2008 | CN100386397C Refrigerant composition, refrigerant auxiliary compositions and uses thereof |
| 05/07/2008 | CN100386116C Sustained release of microcrystalline peptide suspensions |
| 05/07/2008 | CN100386090C Medical dust cloud agent or granular agent and its use |
| 05/07/2008 | CN100386073C Transdermal drug administering system |
| 05/07/2008 | CN100386070C Pharmaceutical formulation comprising melatonin |
| 05/07/2008 | CN100386069C Brilliant mycomycin elaioplast preparation and its making method |
| 05/07/2008 | CN100386068C Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
| 05/06/2008 | USRE40300 Carbon dioxide enhancement of inhalation therapy |
| 05/06/2008 | US7368565 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 05/06/2008 | US7368502 Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 05/06/2008 | US7368481 Pet anti-aging wellness supplement for cats |
| 05/06/2008 | US7368431 Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon |
| 05/06/2008 | US7368295 Nanoparticles comprising biologically active TNF which is immobilized on the same |
| 05/06/2008 | US7368287 For treatment and/or prevention of inflammation and autoimmune disease; vaccines |